Tuesday, September 19, 2017

The Green Organic Dutchman Holdings Ltd. Announces $20M Private Placement as Company Moves toward Expansion


  • Company has, to date, raised $41.5 million and has more than 2,400 shareholders
  • Has one of the largest licensed land parcels in Canada, situated on 100 acres
  • Offers organically grown, pesticide-free medical marijuana under Canada’s ACMPR

The Green Organic Dutchman Holdings Ltd. (“TGOD”), a Canadian company engaged in producing farm-grown, high-quality organic medical cannabis using craft growing, all natural, organic principles, announced on September 11 (http://dtn.fm/8GkWq) that it has entered into an agreement with a syndicate led by PI Financial Corp. to complete a private placement offering of units. The syndicate will offer, on a commercially reasonable effort basis, 4,242,500 units of the company at an issue price of C$1.65 per unit for aggregate gross proceeds of C$7,000,125.

TGOD will also concurrently engage in a non-brokered offering of 7,879,000 units, with each unit being offered at C$1.65 for aggregate gross proceeds of $13,000,350, under the same terms as the unit offering.

Each unit will consist of one common share of TGOD and one-half common share purchase warrant of the company. Each whole warrant is exercisable into one common share at the exercise price of $3.00 per share and has an expiration date that is either 36 months from the date the common shares begin trading on a recognized stock exchange or February 28, 2021, whichever is earlier.

TGOD plans to use the net proceeds of the unit offering and the non-brokered offering to advance its cannabis facilities in Ontario and Quebec, as well as for general working capital purposes.

A private producer of high-grade, organically grown and pesticide-free medical cannabis under the ACMPR, TGOD grows its marijuana in small batches, and its products are laboratory tested to ensure all recipient patients are provided with a standardized, safe and consistent product.

TGOD has a funded capacity of 14,000 kg and has one of the biggest licensed land parcels in Canada, situated on 100 acres. The company also recently secured a second 75-acre, fully serviced site near Montreal and is currently in the process of expanding its cultivation capacity to 116,000 kg and increasing its product offerings preparatory to recreational cannabis use becoming federally legal in Canada in 2018—something the Canadian government is currently making strides toward.

To date, TGOD has raised $41.5 million and has more than 2,400 shareholders.

For more information, visit the company’s website at www.TGOD.ca

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

At ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF), Medicinal Cannabinoid Quality and Safety are Founding Principles


  • Producer of consistent, standardized medicinal cannabis
  • Menu of cannabis strains with varying CBD:THC ratios
  • ABcann’s CBD-Med is one of Canada’s highest-CBD products

In an interview with Cantech Letter (http://dtn.fm/5Deu5), Aaron Keay, CEO of ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF), talked about the factors that triggered the genesis of the company, one of Canada’s trailblazing producers of medicinal cannabis. Ken Clement, the founder of ABcann, with his wealth of experience and knowledge, had observed the variability in consistency and potency of cannabis that was currently available. Although, in general, not much of a bother to recreational users, to those using cannabis for pain relief or other medical purposes, this was causing a great deal of concern.

Inconsistency in product quality makes the determination of optimal dosage levels impossible to achieve. As a result, “to deliver consistent, standardized medicinal cannabis that the public and patients can consistently rely on” became one of ABcann’s founding principles. That principle continues to guide the company to this day. The Canadian-licensed producer recently announced the release of one of Canada’s highest legal CBD:THC ratio cannabis products. This new product expands the range of therapies now available to patients and so increases the efficacy of current treatment regimens in the promising new field of cannabinoid therapies.

At present, the majority of cannabinoid therapies are directed to alleviate the chronic pain resulting from a variety of maladies. Since delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD) are the cannabinoids occurring at the highest concentrations in cannabis, the therapeutic effects of the plant and its derivatives are most likely derived from these components acting alone or together.

This is a line of research that has been explored successfully by GW Pharmaceuticals. The European company produces Sativex, a treatment for the relief of symptoms in patients with moderate to severe spasticity due to multiple sclerosis (MS), which contains a one-to-one ratio of THC to CBD. While many patients have found relief from pain in high-THC cannabis, a subset of these have reported short-term memory impairment, dysphoria (feeling uneasy for no apparent reason), increased levels of anxiety and even panic attacks. Fortunately, CBD is devoid of such malignant manifestations, exhibiting calming and uplifting properties that appear to mitigate the unwanted effects of THC. As a result, strains of cannabis that are rich in CBD, like those produced by ABcann, are most helpful to those averse or intolerant to THC and to patients who want pain relief without too much of a ‘high’.

A look at the stats released by Health Canada will show where ABcann is on the CBD:THC ratio spectrum. Most cannabis strains (54%) on the Canadian market have a high CBD:THC ratio, with THC over 15% and CBD less than 1%. Many others (29%) have less THC but negligible amounts of CBD, with THC less than 15% and CBD under 1%. Only 14% of strains have both THC and CBD levels that exceed 5%, and just 3% of strains have less than 1% THC and more than 9% CBD, a highly prized category in which the latest ABcann strains can be found.

Late last month, the company announced (http://dtn.fm/bAJw6) the release of its top-of-the-line CBD-Med, which has a ratio of 27.6:1 (18.5% CBD to 0.67% THC). This adds to ABcann current lineup of high-CBD products, which already include NC:Med, with 18.9% CBD to 1% THC and DC:Med, with 15.4% CBD to 1% THC. ABcann also expects to be able to sell oils from October 2017, a range that will include a 1:1 THC/CBD drop, a high THC dropper and a high CBD dropper.

For more information, visit the company’s website at www.ABcann.ca

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Greenkraft, Inc. (GKIT) is “One to Watch”


  • Greenkraft, Inc. expects to realize well over $1 million of new revenue in 2017
  • Expansion plans include construction of larger manufacturing facility to accommodate increasing demand for Greenkraft’s alternative fuel commercial trucks
  • A new line of larger, heavy duty G3 and G4 commercial trucks are coming soon
  • Greenkraft vehicles meet EPA and CARB emission standards through use of clean alternative fuels

Greenkraft, Inc. (OTCQB: GKIT) is a nationally recognized company specializing in the production of alternative fuel automotive products, including engines and commercial trucks. Located in Santa Ana, California, the company’s mission is to provide clean, green, energy efficient automotive products that have a price advantage coupled with unparalleled American performance. Established in 2008, Greenkraft, Inc. serves the commercial truck market powered by the alternative fuels CNG and LPG in classes 4, 5, 6 and 7.

Greenkraft’s new line of trucks, known as the G3 and G4, will accommodate weights of 26,000 lbs. and 33,000 lbs., respectively. George Gemayel, CEO of Greenkraft, Inc., said the demand for larger trucks that run on alternative fuels continues to increase.

“Greenkraft is going to revolutionize the trucking industry with these new 26,000 and 33,000 lbs. trucks that run on CNG and PROPANE fuel,” Gemayel states in a press release. “The only way we can meet increased demand for Greenkraft products is to expand our current factory. This expansion is one of many factors that will substantially increase the Company’s revenue in 2017.”

Greenkraft produces a cab forward design for its commercial trucks, which allows the passenger area to be much larger than in other similar sized vehicles. Several tank capacity options exist, making it easy to select the most efficient model for a client’s specific needs. Greenkraft is one of the only companies in the world to offer a refrigeration option with an alternative fuel truck – an essential, must-have option for many businesses.

Greenkraft trucks, considered among the best performing in the heavy-duty market, are used in a variety of industries and in some of the nation’s largest cities. The company also offers a line of trucks designed to run with a package from Allison Transmission Holdings, Inc. (NYSE: ALSN), which gives clients the option of purchasing a fully automatic transmission vehicle. This option expands the size of the driver pool since fully automatic shifting reduces driver fatigue, contributes to solving the issue of driver retention, and it is easy to use.

CNG and LPG conversion systems made by Greenkraft are available for several major automobile brands including Ford, GM and Isuzu/GM. Installation, service, parts and warranty are all available through Greenkraft facilities and its partners.

For more information, visit the company’s website at www.GreenkraftInc.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Patriot One Technologies (TSX.V: PAT) (OTCQB: PTOTF) Scheduled to Attend Extraordinary Future Conference on September 20

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) this morning announced that its management team will be presenting, exhibiting and participating in a panel session at the Extraordinary Future Conference on September 20, 2017, in Vancouver. The conference, presented by Cambridge House International, is expected to provide a tremendous opportunity for Patriot One to showcase its award-winning technology to the investment community. CEO Martin Cronin and Director Jeffery Tindale will both be in attendance and available in booth #3 for one-on-one meetings with prospective investors. Additionally, Cronin will be participating in a panel session on security and artificial intelligence at 10:30 a.m., as well as delivering an investor presentation in the Speakers Hall at 11:40 a.m.

For more information about the Extraordinary Future Conference, visit www.ExtraordinaryFuture.com

To view the full press release, visit http://dtn.fm/ufOw8

About Patriot One Technologies, Inc.

Patriot One has developed PATSCAN CMR™ the next generation of its award-winning radar device and software solution. PATSCAN CMR is a first-of-its-kind Cognitive Microwave Radar concealed weapons detection system, designed as an effective tool to combat active shooter threats before they occur. Built for cost-effective deployment in weapon-restricted buildings and facilities, the Patriot One software solution and related hardware can be installed in hallways and doorways to covertly identify weapons and to alert security of an active threat entering the premises. Owner/operators of private and certain public facilities can now prominently post anti-weapons policies with compliance assured. The Company’s motto Deter, Detect and Defend is based on the belief that widespread use of its technology will act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the globe. For more information, visit: www.patriot1tech.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – PotNetwork Holding, Inc. (POTN) Announces Hurricane Irma Relief Promotion

PotNetwork Holding, Inc. (OTC: POTN) this morning announced that electricity and internet service at Diamond CBD’s corporate headquarters have been restored, and its business is now back up and running smoothly in the wake of what meteorologists have classified as one of the largest recorded hurricanes to hit Florida. As part of the ongoing Hurricane Irma relief efforts, Diamond CBD will be donating 10 percent of all net proceeds for the next three days and offering a 50 percent discount storewide. “Our hearts go out to our community,” Gary Blum, CEO of PotNetwork Holding, stated in the news release. “You never expect to be blindsided by a natural disaster. We have committed to help our neighbors pick up the pieces by contributing 10% of net revenues generated over the next 3 days, as business resumes, and orders are placed for our 50% off hurricane relief promotion.” To take advantage of this promotion, customers should enter code ‘IRMA’ in the promo code selection box upon checkout at DiamondCBD.com.

To view the full press release, visit http://dtn.fm/4zVsD

About PotNetwork Holding, Inc.

PotNetwork Holding, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils. For more information, visit the company’s website at www.PotNetworkHolding.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Retains Consulting Services of Ben Paterson

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced that it has retained the consulting services of Ben Paterson, P.E., to assist in defining the pathway for scale-up, purification and manufacturing strategies related to the company’s cannabinoid biosynthesis program. Paterson brings nearly four decades of experience in developing pharmaceutical manufacturing and purification processes to the InMed team, having previously served as a senior engineering advisor with Pharmaceutical giant Eli Lilly and Company for nearly four decades. “Mr. Paterson brings significant experience in all facets of biosynthesis manufacturing and facility design,” Eric A. Adams, president and CEO of InMed, stated in the news release. “His expertise directing complex capital projects, overseeing facilities and equipment, and interfacing with various stakeholders will be a significant asset to InMed.”

To view the full press release, visit http://dtn.fm/XJ9be

About InMed

InMed is a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. InMed conducts research, discovery, preclinical, clinical, regulatory, manufacturing and commercial development activities for its product candidates. InMed’s proprietary bioinformatics database assessment tool, the biosynthesis manufacturing process and its drug development programs are the fundamental value drivers of the Company. For more information, visit www.inmedpharma.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Monday, September 18, 2017

ProBility Media’s (PBYA) One Exam Prep Division Enters Asset Purchase Agreement with Contractor Exam Preps


  • Acquisition of Contractor Exam Preps of Pittsboro, North Carolina, would give One Exam Prep access to new markets, customers
  • One Exam Prep is already on pace to have 70% gain in year-over-year revenues
  • Chris Barrow, president of Contractor Exam Preps, would join One Exam Prep division as a master instructor

ProBility Media Corp. (OTCQB: PBYA), through its One Exam Prep division, has entered into an asset purchase agreement (http://dtn.fm/S5fHx) with Contractor Exam Preps of Pittsboro, North Carolina. The acquisition would expand One Exam Prep’s markets and customers.

ProBility Media is an EdTech company which offers the skilled trades high quality training courses, eLearning opportunities and materials. The firm is seeking to build an international brand for educating, training and compliance for the skilled trades. It serves small businesses, as well as enterprise-level corporations.

In a news release, Noah Davis, president and COO of ProBility, said, “With sales on pace to exceed a 70% increase year-over-year, combined with the anticipated addition of Contractor Exam Preps, One Exam Prep is poised to enter new markets and offer more to its current and new customers than ever before.”

Chris Barrow, president of 20-year-old Contractor Exam Preps, would join One Exam Prep as a master instructor, per the purchase agreement. “We are very much looking forward to integrating Barrow’s expertise and skill sets into One Exam Prep,” said Rob Estell, founder and president of One Exam Prep. “We currently service 22 states and offer hundreds of high-quality online courses, private e-tutoring, application processing, daily physical classes, and all of the training materials, at very competitive pricing.”

Employer-based formal training in the U.S. is a $177 billion annual market, according to a ProBility presentation within an 8K SEC filing (http://dtn.fm/nO34q). The Trump administration’s infrastructure plans call for an increase in apprenticeships to five million from 40,000 today. Some 60% of the jobs created by the $1 trillion plan will require less than six months of training.

ProBility offers educational and compliance materials for 60 skilled trades in 15 categories. The diverse list of subjects includes electrical, solar, glass glazing, plumbing, air conditioning, irrigation, pollutant storage, and others. It is targeting annual organic revenue growth of 25-30% and 20-25% additional sales through acquisitions, the presentation shows. Further, it is targeting a 30% EBITDA margin.

For more information, visit the company’s website at www.ProBilityMedia.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

HighCom Global Security, Inc. (HCGS) Serves a Global Market with a Focus on Quality Management


  • HighCom’s blast protection products are ISO 9001:2008 certified and meet the quality standards of BA 9000
  • The company has manufactured over a million plates with no operational failures or recalls
  • In Q2 2017, it reported a 116 percent increase in year-over-year revenues, with $1.5 million earned over a three-month period

HighCom Global Security, Inc. (OTC: HCGS), a leader in blast effects mitigation solutions, has introduced several new products in 2017, while continuing to uphold its ISO 9001:2008-certified Quality Management System. This system has been in place since 2005 and was certified the following year. It helps assure approval of all products by the International Organization for Standardization (ISO). HighCom works to meet the basic requirements and continually make improvements. Its plates, helmets, shields, and other types of armor; bullet proof vests; ballistic blankets; and other offerings also adhere to the armor quality standards of BA 9000 certification, established by the National Institute of Justice (NIJ).

The company serves law enforcement, military and government customers, as well as those in the commercial sector. It can offer fire suppression for naval vessels and merchant ships. Products are also available to help protect buildings against vehicle-delivered bombs. In addition, the company supplies a line of rifle armor, civilian armor systems, vest attachments, and bags and pouches.

Just this year, several new products were introduced, including a lightweight and high-performance soft armor panel (the Level IIIa elite) and multi-curve, hard armor ballistic plate (the Level III++). Four new hard armor products were added in February, which have been recognized by the NIJ’s Compliance Testing Program. In terms of body armor, it is the only standard that has been nationally accepted. HighCom’s total of 11 hard armor and five soft armor solutions are certified to the institute’s high quality standards.

Since its founding in February 1997, the company has served a large and diverse market. Over about a decade, it distributed nearly one million pieces of ballistic armor via Department of Defense contracts, and it has capacity to output more than 20,000 pieces of armor each month. This high level of performance doesn’t seem to be slowing down. In a recent news release (http://dtn.fm/Xn5iD), HighCom Global Security reported a year-over-year increase of 116 percent for Q2 revenues. The company reported revenue of $1.5 million for the quarter, and $2.6 million for the first half of the year, which marked a 37.5 percent increase over the first half of 2016.

Its continued success is in part due to an ability to serve the global defense market and adhere to leading standards, but HighCom’s own technical development strategy also plays a role. A ballistic testing laboratory at the company’s Columbus, Ohio R&D center and manufacturing plant is where soft body armor, shields, tactical armor systems, helmets, and other products are developed and quality controlled. Here, testing guarantees 100 percent effectiveness, according to the company, and includes the same tests conducted at NIJ-approved ballistic labs worldwide.

For more information, visit the company’s website at www.HighComGlobal.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Attends Cannabis World Congress & Business Exposition

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that executive management members of its majority-owned subsidiary, MoneyTrac Technology, Inc., successfully represented the company at the fourth annual Cannabis World Congress & Business Exposition held in Los Angeles. “Representation at events such as this present such a unique and powerful opportunity to grow our presence and establish new partnerships within an industry that is incredibly tight-knit and yet growing at an unprecedented rate,” MoneyTrac COO Vanessa Luna stated in the news release. “I am encouraged by the many different connections we established during this expo, and I am optimistic about the likelihood of a decent number of them possibly materializing into new partnerships for our company at some point in the near future.” MoneyTrac is currently making arrangement to ensure representation for the expo’s East Coast dates from October 4-6 in Boston. As noted in the news release, this will “present another opportunity for the Company to promote and create awareness for the effective technology and other industry-specific services and solutions [it offers] to businesses operating in the cannabis industry.”

To view the full press release, visit http://dtn.fm/qS4gj

About Global Payout, Inc.

Since the Company’s inception in 2009, Global Payout, Inc. has been a leading provider of comprehensive and customized prepaid payment solutions for domestic and international organizations distributing money worldwide. In 2014, Global Payout introduced its first online payment platform, called the Consolidated Payment Gateway (CPG), which allowed its enterprise clients to transfer money to international bank accounts, mobile accounts, and prepaid card accounts. The development of the CPG became the foundation for the introduction of its new, state-of-the-art FINTECH payment system in 2017, designed for both online and mobile applications to allow account holders to maximize an expanded suite of financial services and minimize operational costs. Global Payout will continue to offer its FINTECH payment system to many vertical markets for support of foreign currency exchange and digital currency, including ongoing support of the banking industry and international governments. For more information, visit www.GlobalPayout.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Nets Total Proceeds of $11.9 Million from Exercise of Warrants

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has received total proceeds of nearly $11.9 million from the exercise of an aggregate of 19,185,965 warrants since the closing of its acquisition of ABcann Medicinals Inc. on April 28, 2017. With these funds, ABcann’s current cash position stands at approximately $45 million, giving the company the means to execute previously outlined plans to expand its production capabilities. “ABcann thanks our shareholders for their continued support and confidence as we work toward expanding our facilities and increasing production,” Aaron Keay, director and CEO of ABcann, stated in the news release. “Our strong financial position, represented by our current cash position is earmarked for new construction and will facilitate the timely execution of our business plan. The Company’s main focus in the coming months will be on the deployment of capital towards the expansion of our existing Vanluven facility and development and construction of the new Kimmett facility, as well as the pursuit of our international expansion plans.”

To view the full press release, visit http://dtn.fm/8NMaz

About ABcann Global Corporation

ABcann Global Corporation’s wholly owned subsidiary, ABcann Medicinals Inc., was one of the first companies to obtain a production license under the Marijuana for Medical Purposes Regulations, which it received on March 21, 2014. It obtained a sales license on December 31, 2015. ABcann’s flagship facility in Napanee, Ontario utilizes proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. This approach and the systems in place allow ABcann to produce organically grown and pesticide-free, high-yielding plants, which, in turn, can generate high-quality products that are consistent from batch to batch. ABcann is able to control environmental and nutrient demands, tailor-made for a particular strain of cannabis, without the variation that is typical when producing large quantities in less-controlled, larger rooms and greenhouse-type structures. ABcann’s modular approach to systems technology eliminates scale-up risk and allows ABcann to locate anywhere in the world and maintain consistency and quality of product. ABcann is expanding capacity in its current facility to approximately 30,000 sq ft and concurrently undertaking its expansion into a new 150,000 sq ft facility in Napanee. ABcann is pursuing opportunities in Germany, Australia, Israel and other jurisdictions as well as exploring the development of multiple delivery vehicles. For more information, visit www.abcannglobal.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Subsidiary Completes China FDA Filing; Moves toward Launch of Hemp-Infused Skin Care Line

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary CBD Biotechnology Co. Ltd., this morning announced that it has completed the record filing process with the China Food & Drug Administration (“CFDA”) for its first line of non-industrial hemp-infused skin care products. Following this milestone, the company expects to launch its ‘CBD Magic Hemp Series’ skin care line in the next couple of months, effectively positioning CBD Biotechnology as a leader in what the company has called “an untapped segment of China’s skin care industry.” “I am very pleased to announce the upcoming launch of CBD Biotechnology’s non-industrial hemp-infused skin care line, CBD Magic Hemp Series,” Summer Yun, CEO of CBD Biotechnology, stated in the news release. “We have not only completed the filing process with CFDA, but we have also contracted with a large processing factory in Shanghai, China, with over 14-years of experience in cosmetics production.” Upon launch, the initial CBD Magic Hemp Series product line is expected to include a brightening and refreshing moisturizer, a perfecting shield primer and a peptide collagen solution.

To view the full press release, visit http://dtn.fm/E537f

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products. For more information visit www.ChineseInvestors.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Friday, September 15, 2017

QualityStocksNewsBreaks – University of British Columbia to Conduct Clinical Study of Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Game-Changing Oral CBD Product

While cannabidiol and other marijuana-derived substances are traditionally smoked, this can cause damage to the lungs, and edible cannabis products have their drawbacks, too—typically being filled with sugars or other sweeteners to mask the unpleasant flavor associated with cannabis compounds. With its pioneering TurboCBD™ product, however, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral CBD intake, having engineered the product to enhance absorption through the intestinal tract without active compounds being destroyed by stomach acid or broken down by the liver, and this revolutionary product also masks the unpleasant flavor of cannabis compounds. An article further discussing this topic reads: “In August 2017, the University of British Columbia (UBC) announced (http://dtn.fm/5NgxC) that it will conduct the first clinical study of the high-absorption product while evaluating its effects on cognitive function and cardiovascular health of human volunteers. Currently, Lexaria is the only company to have been awarded a patent for delivery of ingestible non-psychoactive cannabinoids. It holds patents in the U.S. and Australia, and more are pending in over 40 other countries. The upcoming UBC study will be double-blind and placebo controlled. Researchers will measure the effects after a single dose and after seven days of daily doses. The 24 volunteers will consist of young and old individuals, whose glucose, blood pressure, vascular function, cognition, and physical performance will be measured. Blood samples, exercise tests, heart rate, respiration, and neuropsychological tests, among other measurements, will be conducted as well. These tests will provide a complete set of pharmacokinetic and pharmacodynamic performance data of Lexaria’s TurboCBD™.”

To view the full article, visit http://dtn.fm/MdTg7

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit www.LexariaBioscience.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – AppSwarm, Inc. (SWRM) Leverages Growth Strategy by Focusing on Key Revenue Streams

Building on $589,000 in revenue earned in 2016, AppSwarm, Inc. (OTC: SWRM) is going strong in 2017 with a vigorous growth strategy that is centered on a proprietary business model, known internally as the “Swarm.” This strategy involves measures like in-house development and assets gained through mergers and acquisitions. An article further discussing this topic reads: “The four key revenue streams driving the company’s progress include the incubation of apps, using completion of concept and development, market analysis, sales/marketing, and financial management services. AppSwarm is also highly engaged in social game development. It has developed highly relevant concepts internally, although it has also been successful in purchasing and redeveloping existing games and applications. Focusing on specialty niches has boosted revenue as well, especially casino and role-playing movie-themed applications. Several projects have involved partnerships leveraging technology and market expertise, allowing the company to apply each product to the specific market in an appropriate way.”

To view the full article, visit http://dtn.fm/7NMcx

About AppSwarm

We develop and publish mobile gaming apps, with a focus on accelerating the development of free to play mobile games and fast-track them to market. We partner with game developers through joint ventures, royalty agreements, marketing partnerships, and outright purchases through our publicly-traded company on the OTC Markets, ticker SWRM.For more information, visit us at http://www.app-swarm.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Algae Dynamics Corp. (ADYNF) Collaborates with Prominent Neuroscientist to Research Cannabinoid Potential in Treating Mental Health Disorders

Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company engaged in developing proprietary research as well as products derived from cannabis and hemp oils, has commenced a collaborative relationship with Dr. Laviolette, a neuroscientist at the University of Western Ontario, Canada, who is examining the treatment potential of cannabinoids in addressing disorders like addiction, schizophrenia, depression and post-traumatic stress disorder. Dr. Laviolette has been seeking ways to more effectively utilize chemicals found in marijuana to treat some of these illnesses, while Algae Dynamics has been taking a holistic approach by examining specific cannabinoids found in marijuana and combining that research with expertise in extracting various nutritional dietary products, like Omega-3 fatty acids. An article further discussing this topic reads: “Emerging research shows that Omega-3 fatty acids can have very strong interactions with the brain’s natural or biological endocannabinoid system and can also modulate the effects of cannabinoids on the brain. If there is a dietary deficiency of Omega-3 fatty acids, the brain’s natural cannabinoid system is not going to work with optimal efficiency,” Dr. Laviolette explained. “’By contrast, if you can supplement with Omega-3 fatty acids you see certain improvements in the brain’s cannabinoid system, so that immediately got us interested in how synergies between Omega-3 fatty acids and cannabinoids that are derived from marijuana might serve as potential, novel pharmaceutical and nutraceutical products for treating certain specific mental health disorders.’ The brain’s natural cannabinoid system is involved in a lot of different processes that relate to mental health, including mood regulation, one’s ability to learn and remember, and certain cognitive tasks.”

To view the full article, visit http://dtn.fm/R74Pb

About Algae Dynamics Corp.

ADC is engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. We have engaged two Canadian universities to provide research into the use of extracts from cannabis oil, which we plan to use to develop products that combine the significant health benefits of Omega-3s derived from algae oil and extracts from cannabis oil. Our research is focused on the use of cannabis oil in the context of cancer, and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health. For more information, visit http://www.algaedynamics.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Recent Competitor Recalls Illustrate Importance of ABcann Global’s (TSX.V: ABCN) (OTCQB: ABCCF) Innovative, Pesticide-Free Cannabis Growth Practices

Recently, the Canadian government announced that Broken Coast Cannabis Ltd. was recalling several products sold in 2016 due to the discovery of two banned pesticides in random samples, and several other Canadian cannabis growers have also had product recalls this year after banned pesticides were discovered in their products during mandatory testing. Instances like these serve to further illustrate the importance of the controlled, pesticide-free medical marijuana growth practices of ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), which continues to meet product demand through its Napanee, Ontario, production facility and is also moving forward with expansion plans. An article further discussing this topic reads: “ABcann has moved methodically through each stage of our growth since first obtaining our license in 2014,” founder and director Ken Clement said in an update published on the ABcann website. “Providing a high quality, standardized pesticide-free product to our patients remains our number one priority as we initiate our largest expansion plans to date.”

To view the full article, visit http://dtn.fm/F9Jdn

About ABcann Global Corporation

ABcann Global Corporation’s wholly owned subsidiary, ABcann Medicinals Inc., was one of the first companies to obtain a production license under the Marijuana for Medical Purposes Regulations, which it received on March 21, 2014. It obtained a sales license on December 31, 2015. ABcann’s flagship facility in Napanee, Ontario utilizes proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. This approach and the systems in place allow ABcann to produce organically grown and pesticide-free, high-yielding plants, which, in turn, can generate high-quality products that are consistent from batch to batch. ABcann is able to control environmental and nutrient demands, tailor-made for a particular strain of cannabis, without the variation that is typical when producing large quantities in less-controlled, larger rooms and greenhouse-type structures. ABcann’s modular approach to systems technology eliminates scale-up risk and allows ABcann to locate anywhere in the world and maintain consistency and quality of product. ABcann is expanding capacity in its current facility to approximately 30,000 sq ft and concurrently undertaking its expansion into a new 150,000 sq ft facility in Napanee. ABcann is pursuing opportunities in Germany, Australia, Israel and other jurisdictions as well as exploring the development of multiple delivery vehicles. For more information, visit www.abcannglobal.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

ProBility Media Corp. (PBYA) Professional e-Learning and Training Addressing Rising Demand for Skilled Labor


  • ProBility now offers leading vocational educational materials in 60+ fields, including the electrical, construction, plumbing and security industries
  • An overwhelming majority of technical employers are struggling to find workers with the appropriate skills
  • Technical high schools are simulating workplaces to prepare students for their careers in historically underprivileged areas

Access to technology-based education resources is becoming open to more people. Even as the National Center for Education Statistics reported about 20.5 million students (fall 2016) were enrolled in colleges and universities throughout the U.S., career training and advancement materials are becoming more available to those looking for jobs requiring skilled labor. ProBility Media Corp. (OTCQB: PBYA) is a growing brand serving the training requirements for several different technical fields. In many of these, 95 percent of employers are having trouble finding workers with the right skills in 2017, based on U.S. Chamber of Commerce data published in a recent report (http://dtn.fm/5JQKg) on skilled labor demand.

Thanks to several recent acquisitions, ProBility can now provide study materials for electricians, construction workers, contractors, and plumbers, as well as many other skilled trades. The company provides access to all the latest NEC National Electrical Codes, with books, reference guides, and digital media available on CD and DVD. It has also reached into the public safety market. The launch of ProBility Safety Academy means training is open to those looking to advance their potential in public safety, private security, criminal justice, and police science.

The need for vocational training services is reaching from coast to coast. High school teachers and students alike are benefiting. In fact, technical high schools are cropping up in places like Huntington, West Virginia, as a recent New York Times article pointed out (http://dtn.fm/BOQ8g). Four teachers at a summer training program worked on a miniature boiler similar to larger counterparts found at power generating plants. The educational programs they’re preparing for will simulate workplaces and include everything from vocational training to random drug testing, to get students familiarized with work environments and prepared for future careers.

Simulated workplaces also have real-world equipment, ranging from drafting tables and welding torches to stethoscopes and 3D printers. Laser engraving equipment and professional software are expected to be used, from leading brands like AutoDesk Inventor. As part of the program, students will also get breaks during the day as employees working for technical organizations do.

ProBility is focused on providing a one-stop resource. Therefore, small- and medium-sized businesses can access e-learning resources, so they can offer employees training and career advancement opportunities. Its efforts to provide a single source of training materials does not stop at the borders of the United States. The recent acquisition of Cranbury International extends the company’s e-learning reach into the Caribbean, Mexico, Columbia, Brazil, and other countries in Central and South America.

For more information, visit the company’s website at www.ProbilityMedia.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

ChineseInvestors.com, Inc. (CIIX) Sets Goal of Greater than 100% Gain in FY2018 Revenues


  • In FY2017, the company’s investor relations business grew 130%, and its subscriptions business rose by 57%
  • Warren Wang, founder and chief executive officer of CIIX, sets goal of greater than 100% gain in sales in FY2018 and cost-cutting to achieve profitability
  • Company excited about its expansion of auxiliary services into the digital currency industry; Wang says that market will offer long-term opportunities

ChineseInvestors.com, Inc. (OTCQB: CIIX) recorded a skyrocketing 76% year-over-year operating revenues increase for its fiscal year ended May 31, 2017. The company’s two divisions exhibited double-digit and triple-digit growth in FY2017. The investor relations business grew 130%, while the subscriptions business rose 57% during the 2017 fiscal year, the company reported (http://dtn.fm/wLt1F). Total sales grew to $1,667,977 in FY2017 compared to $948,385 the prior year.

Warren Wang, founder and chief executive officer of CIIX, says the company’s goal is more than a 100% jump in FY2018 sales, while cutting costs and achieving profitability.

The primary reason for the increase in sales for the two divisions was a decision by management to be more discerning in deciding which companies would receive its investor relations services. Also, the firm placed itself on a more cash compensation basis — resulting in more sales — rather than taking equity compensation.

CIIX has a goal of becoming the primary Chinese medical cannabis publicly traded company. It is focused on the R&D and distribution of legalized, hemp-based cannabidiol (CBD) to the global Chinese-speaking community. It maintains an online store in the free trade zone of Shanghai, China, and plans on opening a brick-and-mortar outlet in San Gabriel, California.

Before the end of 2017, CIIX plans to launch a cryptocurrency education and trading subscription service and the first Chinese daily video news broadcast from the NYSE covering digital currency and blockchain technology. It has also established CBD Biotechnology Co., Ltd., as a wholly-owned subsidiary in Shanghai, China. It launched OptHemp, its first hemp oil product line. In the coming months, the company said, it will unveil in China its first hemp-infused skin care product line.

“I am very pleased about the Company’s significant increase in revenue in the fiscal year ended May 31, 2017,” Warren Wang, founder and chief executive officer of CIIX, stated in a news release. “Although the blueprint of our Company’s business strategy has expanded through its entrance into the Hemp Industry, our core subscription and investors relations services remain strong with significant growth rates. I am thankful for the investors who have supported our ongoing development plans and look forward to a prosperous year ahead.”

For its non-industrial hemp-based products, the company has engaged Scottsdale, Arizona-based Launch Haus LLC to help it in its direct response marketing, digital, e-commerce and direct sales channels.

In addition, the company has thus far realized $2 million through August 29, 2017, from its private placement of some 10 million shares of its Series D-2017 convertible preferred stock, priced at $1 per share.

For more information, visit the company’s website at www.ChineseInvestors.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Thursday, September 14, 2017

QualityStocksNewsBreaks – Bollente Companies, Inc. (BOLC) Reaches Millennials with trutankless® Smart Water Heater System

Bollente Companies, Inc.’s (OTC: BOLC) trutankless® water heaters are likely to be more appealing to tech savvy millennials than more traditional models, as they can be managed from anywhere in the world using a smartphone. An article further discussing this topic reads: “The trutankless smart water heater system can be managed by logging in to a customizable online control panel. From the dashboard, residential and commercial users can obtain real-time status reports, adjust unit temperature settings, view up to three years of water usage data and change notification settings from anywhere in the world, using a computer or web-enabled smart device. Additionally, service professionals can use the dashboard to monitor system status on every unit they install, allowing them to proactively contact their customers if a service or warranty appointment is needed. The smartphone apps, which allow monitoring and control of the tankless systems, are available for download from the Google Play and Apple iOS stores.”

To view the full article, visit: http://dtn.fm/7jqlW

About Bollente Companies, Inc.

Founded in 2010, trutankless, a division of Bollente Companies, Inc. (OTC: BOLC) is in the early stages of developing a diverse portfolio of companies, targeting disruptive technologies that positively impact the environment and emerging economies. Founded in 2010, trutankless, a division of the company, was brought to life through the combined insight, ingenuity, and drive of industry professionals, engineers, and entrepreneurs. The objective was to create a line of electric tankless water heaters that far surpasses traditional tank water heaters in energy efficiency, output, dependability and environmental sustainability while overcoming the frustrating drawbacks of other tankless units on the market today. The trutankless mission is to efficiently provide hot water on demand by combining smart engineering with forward-thinking technologies that save owners money, energy, and space. For more information, please visit www.trutankless.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – PotNetwork Holding (POTN) Subsidiary Secures More Than $200,000 in Sales at Recent Trade Show

Diamond CBD Sales, a subsidiary of PotNetwork Holding, Inc. (OTC: POTN), attained more than $200,000 in sales at the Big Industry Trade Show in New York on August 10-11. An article further discussing this topic reads: “In addition to the $200,000 at the BIG Industry Trade Show, Diamond CBD also generated sales of more than $320,000 at the Market Week Event, held in Las Vegas. Late in July, the firm also recorded revenues of some $300,000 at the CHAMPS trade show in Las Vegas, PotNetwork Holding said.”

To view the full article, visit: http://dtn.fm/Npte6

About PotNetwork Holding, Inc.

PotNetwork Holding, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils. For more information, visit the company’s website at www.PotNetworkHolding.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

AppSwarm, Inc. (SWRM) Targeting Revenues of $6-7 Million by FY2018


  • SWRM restructures as one company with two divisions, capitalizing on synergies between MediaPlay and Incubation and Acquisition Development
  • Ron Brewer, CEO and director, forecasts significant revenue growth in FY2017, cites strong initial revenues in FY2016
  • New management team at SWRM, with extensive acquisition experience, is seasoned in growing emerging companies

AppSwarm, Inc. (OTC: SWRM), under its new management team, has restructured as one company split into two divisions, and management hopes to achieve revenues of $6-7 million by FY2018, Ron Brewer, the company’s CEO and director, noted in a recent news interview (http://dtn.fm/6Wu2I).

AppSwarm is an application acceleration company in the multi-platform games industry that engages in joint ventures, acquisitions and international opportunities. It now has two divisions. One is MediaPlay, targeting opportunities internationally and focused on joint venture efforts and larger projects, such as supplying TV channels with services. MediaPlay is an international multi-platform games publisher and developer acquired in mid-August by SWRM. The other division is Incubation and Acquisition Development (IAD), which is focused on the incubation program and direct acquisitions, as well as gaming opportunities, interactive development and e-commerce business solutions to enhance SWRM’s organic growth.

SWRM’s management team may be new, but it is very experienced in business management, the mobile games market, achieving joint ventures, licensing and aiding games developers as an incubator. Brewer, who joined SWRM last year, has served as managing director of Southbridge Advisory Group since 1990. Southbridge is a boutique firm focused on management services and M&A. John Rabbitt, SWRM’s CFO and director, has an extensive and diverse business background, having held positions at The Pillsbury Company and PepsiCo.

In addition, Chris Gray, president of the studios at MediaPlay, is a 30-year veteran of the video game industry. Steve Wall, president of publishing at MediaPlay, is a 23-year industry veteran who founded or co-founded five game companies and oversaw the launch of greater than 600 games.

“We want to get both divisions fully launched and out in market,” Brewer said in the interview. “We see a possibility, probability, and our managers are wanting to forecast for 2018 somewhere between $6 million and $7 million in revenue.”

For more information, visit the company’s website at www.App-Swarm.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Builds Moat around Proprietary Biosynthesis Technology


  • Proprietary biosynthesis process to produce cannabinoids
  • Provisional patent application filed
  • Cost-effective methodology to produce trace cannabinoids

If you have any doubt that InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is on the right track as it moves to protect its biosynthesis technology for cannabinoids, then a word from a famed figure may make you change your mind. Known worldwide for his investing prowess, Warren Buffett has said, “I don’t want a business that’s easy for competitors. I want a business with a moat around it with a very valuable castle in the middle” (http://dtn.fm/9al5F). Naturally, the Sage of Omaha was referring to an economic moat and not its tangible water-filled counterpart. One obvious way of constructing such an economic moat would be by registering a patent, which is exactly what InMed is planning to do. The company, which specializes in the research and development (R&D) of novel, cannabinoid-based drug therapies, has announced the filing of a provisional patent application for its proprietary biosynthesis process for the manufacture of cannabinoids that are identical to those found in nature (http://dtn.fm/I8g3M).

This filing is the first step in setting up defenses. Under U.S. patent law, a provisional patent application filed with the United States Patent and Trademark Office (USPTO) allows the filer to get a filing date and book a place in the queue. But, just as importantly, it affords protection for up to 12 months without filing a complete patent application. The provisional application may later be converted into a non-provisional one or be replaced by a regular patent application. The process in Canada, although not the same, is very similar.

To obtain protection outside North America, the Patent Cooperation Treaty (PCT) offers one streamlined route. The PCT procedure facilitates a patent application in all contracting states that are signatories with one filing, obviously a boon, since 145 sovereign states are members of the PCT. The PCT process allows the filing of an “international patent application,” which acts as an initial application for a patent in any member country. However, an “international patent application” never matures into an “international patent”. No such animal exists. A PCT filing simply reduces the burden of individual filings to contracting states and acts as a patent application to the contracting state in which the patent is meant to go into effect. Patents are issued by sovereign states and are always limited to national boundaries.

InMed’s provisional patent application will protect the biosynthesis process it has developed for the production of cannabinoids. In itself, biosynthetic production of chemicals is nothing new, but it really took off in 1978 after Genentech succeeded in modifying Escherichia-coli (E-coli) bacteria to produce synthetic insulin, a breakthrough credited with saving thousands of lives. Insulin is required by diabetics, whose bodies either do not produce the hormone or handle it inefficiently, in order to absorb glucose. In its absence, blood sugar increases to levels that may damage internal organs. Before biosynthesis, insulin was produced from the pancreas of pigs and cows in a costly, rather inhumane process.

InMed’s biosynthesis technology involves a process that can be applied to manufacture all the naturally occurring cannabinoids, through which the DNA of the cannabinoid to be produced is applied to Escherichia-coli (E-coli) bacteria. The E-coli DNA is then removed, leaving just the cannabinoid DNA, which can then replicate and multiply. This process combines the inherent safety and known efficacy of the natural drug structures with the convenience, control and quality of a laboratory-based manufacturing process.

InMed’s biosynthesis methodology will likely be used to produce the less naturally occurring phytocannabinoids such as delta-8 tetrahydrocannabinol (Δ8 THC), cannabidivarin (CBDv), and tetrahydrocannabivarin (THCv), although, for the present, the company is not saying. Regardless of which cannabinoid castles InMed decides to build, they will all be protected by a sturdy economic moat.

For more information, visit the company’s website at www.InMedPharma.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ORHub, Inc. (ORHB) Enlists ICHOM in Effort to Advance Value-Based Health Care Model

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) today announced that it has become a Technology Affiliate of the International Consortium for Health Outcomes Management (“ICHOM”), a non-profit organization focused on advancing value-based health care through the standardized measurement and reporting of patient outcomes. ICHOM is expected to aid ORHub’s ongoing efforts to facilitate a shift toward a value-based health care model by developing and promoting the adoption of core outcome sets that focus on meaningful indicators of patient functional outcomes, including health-related quality of life, mobility and pain levels following treatment. “Our mission is to improve value, which should be defined by the outcomes achieved relative to the cost of delivering those outcomes,” Wesley Mitchell, chief technology officer of ORHub, stated in the news release. “As a technology company, we’ve been effective in figuring out the true cost of surgical procedures, but we needed an independent organization to define the standard for quality.”

To view the full press release, visit http://dtn.fm/m2Dw1

About ORHub, Inc.

ORHub is a medical software company focused on delivering case-based data analytics at the speed of surgery. The Company’s suite of products serves the needs of the health care industry, hospital, patient, government and the medical device vendor. ORHub provides a cloud-based software solution that captures information before, during and after surgery, filling a void in the current surgical information infrastructure and providing the first process to capture and measure the surgical process — evolving Big Data into Intelligent Digital Data. For more information, visit www.ORHub.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Wednesday, September 13, 2017

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral CBD Product to Be Tested by the University of British Columbia


  • The University of British Columbia (UBC) will conduct a double-blind study of Lexaria’s TurboCBD™ oral ingestion product
  • TurboCBD™ masks foul tastes, protects pharmaceutical ingredients during stomach passage and increases intestinal absorption by 5-10x
  • The UBC study will include 24 volunteers and test their cognitive and cardiovascular function after single doses and after seven days of administration

Traditionally, cannabidiol (CBD) is ingested via inhalation, which can harm the lungs, and many edible products contain unwanted sugars or sweeteners. Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral intake with its TurboCBD™ product. Engineered to increase absorption through the intestinal tract, without active compounds destroyed by stomach acid or broken down by the liver, the product also masks the flavor of compounds with undesirable tastes. In August 2017, the University of British Columbia (UBC) announced (http://dtn.fm/f8UPH) that it will conduct the first clinical study of the high-absorption product while evaluating its effects on cognitive function and cardiovascular health of human volunteers.

Currently, Lexaria is the only company to have been awarded a patent for delivery of ingestible non-psychoactive cannabinoids. It holds patents in the U.S. and Australia, and more are pending in over 40 other countries. The upcoming UBC study will be double-blind and placebo controlled. Researchers will measure the effects after a single dose and after seven days of daily doses. The 24 volunteers will consist of young and old individuals, whose glucose, blood pressure, vascular function, cognition, and physical performance will be measured. Blood samples, exercise tests, heart rate, respiration, and neuropsychological tests, among other measurements, will be conducted as well. These tests will provide a complete set of pharmacokinetic and pharmacodynamic performance data of Lexaria’s TurboCBD™.

Regarding the expected outcome of the study, professor Philip Ainslie, PhD, stated in the recent report, “…To quantify the pharmacokinetics of TurboCBD™ will allow us to make informed recommendations of optimum dosing in order to improve vascular health and performance throughout healthy aging. Once we understand these processes better, the applications to various clinical populations can then be explored…”

Details of the test results are expected to be released once the study is completed and the data are interpreted.

According to Lexaria, its “plant-to-bloodstream” product amplifies intestinal absorption by 5-10x. It uses fatty acids, which combine with the active pharmaceutical ingredient to block them from bitter taste receptors on the tongue. Active ingredients are protected by lipids as they pass through the stomach. In the small intestine, long chain fatty acids are absorbed directly into the lymphatic system, while medium chain fatty acids are absorbed via the liver.

An August 2015 in vitro absorption study, conducted in a third party lab, found a 499 percent increase in CBD bioabsorption in the intestines. A human focus study in March 2016 revealed the onset of THC effects in 15 to 20 minutes, while test subjects praised the taste of the product. The company also entered into a collaborative research agreement with Canada’s National Research Council, which was signed in February 2017.

For more information, visit the company’s website at www.LexariaEnergy.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

LottoGopher Holdings, Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG) Names William Shatner Company Spokesperson


  • The holding company, through its subsidiaries, operates in California and permits players to buy, manage their Lotto tickets online, and receive exclusive special lottery news
  • Eyeing expansion in the U.S., LTTGF has hired legal contractor to begin due diligence process for launch into other states
  • James Morel, president and CEO, said online site has been redesigned, marketing campaigns readied, as company now operates in the $6.3 billion lottery market in California

LottoGopher Holdings, Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG) has named William Shatner as its spokesperson, the company announced (http://dtn.fm/h7cPd). One of the world’s best-known actors, in addition to being a director, author, and singer, Shatner is a pop icon figure and Canadian-born personality. Shatner has starred in Star Trek, Boston Legal, and T.J. Hooker, and he has appeared in numerous other TV shows, movies, and plays.

LTTGF, based in Vancouver, British Columbia, operates in California as a lottery messenger service that permits users to not only buy state lottery tickets, but also manage them, using debit or credit cards online. LTTGF users can play alone with a single ticket or join online public or private groups to pool winnings from lotteries, including Powerball, Mega Millions and Super Lotto Plus. LTTGF also enables Californians to keep track of their winnings while participating in multiple lottery contests with multiple tickets. It gives members exclusive lottery news, jackpot alerts and lucky number pickers.

“I am very happy to be joining the LottoGopher team,” Shatner stated in a news release. “Much like Netflix disrupted the movie rental business and Uber hailing a cab, LottoGopher is disrupting the lottery industry for Americans.” He noted that LTTGF enables consumers to buy lottery tickets online in a cost-effective manner and that he looks forward to helping their customers dream big.

In 1997, Shatner teamed with discount travel site Priceline (NASDAQ: PCLN). The Nasdaq-listed stock had an IPO price of $16 per share before skyrocketing to $1,868. Today, the company has a market cap of $99 billion.

In a recent news release, James Morel, president and CEO of LTTGF, said, “We are beyond thrilled that William Shatner has agreed to collaborate with us to accelerate awareness of the brand as our spokesperson.” A humorous digital marketing campaign is also being readied.

He added that Shatner would open up a “huge audience base” for LTTGF’s online messenger service. “He is one of the most recognizable celebrities in the world.”

For a direct link to the William Shatner video, go to http://dtn.fm/fs0LD

For more information, visit the company’s website at www.LottoGopher.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

ProBility Media Corp. (PBYA) Consolidating Skilled Trades Industries eLearning and Training Resources


  • Offering superior online training for small/medium-sized businesses, previously accessible to only larger companies
  • Recent acquisitions and joint ventures have expanded ProBility’s offerings to include more products and cover more industries than ever before
  • Company now includes Brown Technical Media Corp., Brown Technical Publications Inc., Brown Book Shop, Inc., National Electrical Wholesale Providers, W Marketing, One Exam Prep, LLC, ProBility Safety Academy, ProBility Immersive Technologies, Cranbury International and its partnership with GlobalSim Inc.

ProBility Media Corp (OTCQB: PBYA) has been driven to serve as many customers in diverse fields as possible, and a solid acquisition and growth strategy has helped it become an emerging leader in the eLearning and training segment. It is developing a full-service training and career advancement brand that is benefiting small- and medium-sized companies that can now have access to the same resources as their larger counterparts. Its product offerings include high-tech training that incorporates intensive interactive media such as virtual reality and 3D modeling. Thanks to ProBility, clients can find these products and more without having to resort to gathering them from multiple sources, saving time, effort and money.

Having recently acquired National Electrical Wholesale Providers and W Marketing, Inc., ProBility now serves the electrical industry. A variety of educational courses and exam preparation products are accessible through the company’s website. Any electrical contractor can obtain the training they need and learn how to properly install, maintain, and repair power, lighting, and communication systems. There is also a digital media library of intellectual property animations, plus subscription services that energy/industrial employers can take advantage of.

The EdTech company has expanded its scope as much as its industry reach. With the purchase of Cranbury International, it can now offer the same breadth of service to the Caribbean, Central America, and South America. It also now offers heating ventilation and air conditioning training via Brown Technical, plus training materials on ASTM codes and standards, and plumbing and pipefitting training courses, handbooks, and other materials.

Its 1 Exam Prep division enables ProBility to offer access to exam preparation at the state, county, or OSHA level. Many of these are business- and industry-specific, allowing those preparing for such examinations to perfect their test-taking skills ahead of time. There are also numerous resources for employers that want to manage their training on-premises.

An expanding set of training, compliance and career advancement materials are open to businesses in over 60 trades. Electrical, HVAC, plumbing, crane operations and boilermakers are just a few of them. The ProBility Safety Academy, a joint venture with Range Guard and Investigations, extends courses and exam-prep materials to law enforcement, private security and criminal justice segments in a more accessible way than ever before.

ProBility has rapidly become a source of comprehensive online training and exam preparation in multiple industries. Quick and direct access via the Web means that employers don’t have to look far to provide their workforce with industry-leading training that will boost the career potential of their workers and provide these organizations with well-prepared and informed individuals.

For more information, visit the company’s website at www.ProbilityMedia.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Enters Letter of Intent with BlazeNow, Inc.

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., has executed a Letter of Intent with BlazeNow, Inc., a majority owned subsidiary of MediaTechnics Corporation (OTC: MEDT). BlazeNow, once called the “Yelp” of the cannabis industry by NY Daily News, is an advertising and data collection platform focused on connecting cannabis-related businesses with patients and customers. “We are excited to lay the groundwork for what we believe will be a very productive business partnership with BlazeNow,” Vanessa Luna, COO of MoneyTrac Technology, stated in the news release. “The goals are to leverage this partnership in pursuing joint revenue products and services. Through this LOI, we hope to establish a joint-venture partnership with BlazeNow so that we can pool each of the industry-specific resources we have available to help significantly grow both brands.” This morning’s announcement follows the recent launch of BlazeNow’s new app on both Android and iOS platforms, a milestone that’s expected to strategically position the brand for collaborative efforts with MoneyTrac Technology as it looks to achieve broader expansion initiatives.

To view the full press release, visit http://dtn.fm/yAzE4

About Global Payout, Inc.

Since the Company’s inception in 2009, Global Payout, Inc. has been a leading provider of comprehensive and customized prepaid payment solutions for domestic and international organizations distributing money worldwide. In 2014, Global Payout introduced its first online payment platform, called the Consolidated Payment Gateway (CPG), which allowed its enterprise clients to transfer money to international bank accounts, mobile accounts, and prepaid card accounts. The development of the CPG became the foundation for the introduction of its new, state-of-the-art FINTECH payment system in 2017, designed for both online and mobile applications to allow account holders to maximize an expanded suite of financial services and minimize operational costs. Global Payout will continue to offer its FINTECH payment system to many vertical markets for support of foreign currency exchange and digital currency, including ongoing support of the banking industry and international governments. For more information, visit www.GlobalPayout.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Tuesday, September 12, 2017

Algae Dynamics Corp. (ADYNF) Collaborating with Prominent Neuroscientist to Research Benefits of Cannabis Oil for Mental Health Disorders


  • Partnership between Algae Dynamics and Dr. Steven Laviolette focuses on medical benefits of cannabis and hemp oils for various mental health disorders
  • Canada is moving to legalize cannabis throughout the country in 2018, which could radically change research playing field
  • Canadian cannabis oil extraction market projected to reach $1.5 billion by 2020

Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company focused on the development of proprietary research and products derived from cannabis and hemp oils, has begun a collaborative relationship with one neuroscientist who is looking deep within the brain for answers to some of the world’s most pressing mental health problems.

This research agreement with Dr. Laviolette, a neuroscientist at the University of Western Ontario, Canada, is no small thing. The level of human misery and the resulting global economic burden caused by neurological and mental health disorders is hard to fathom. The World Health Organization reports that failure to adequately address and provide effective treatment for depression and other anxiety disorders could cost the world $1 trillion each year, according to research published in The Lancet (http://dtn.fm/8bROv).

“I started working with Algae Dynamics in the spring of this year and it’s going really well, we’re already making quite a bit of progress,” Dr. Laviolette said. “They’re very open-minded and they appreciate the science. They understand the best products come from the best quality science, so I’m very excited to be working with them.”

Algae Dynamics approached Dr. Laviolette, because he was already examining how cannabinoids can treat disorders such as addiction, schizophrenia, depression and post-traumatic stress disorder.

“We’ve been looking at how we can more effectively utilize different chemicals that are found in marijuana to serve as more effective treatments for some of these devastating illnesses,” Dr. Laviolette says. “Algae Dynamics was taking a holistic approach to this research by not only looking at the specific cannabinoids in marijuana, but they also have a background in the extraction of various nutritional dietary products such as Omega-3 fatty acids. That was very exciting for me.”

Emerging research shows that Omega-3 fatty acids can have very strong interactions with the brain’s natural or biological endocannabinoid system and can also modulate the effects of cannabinoids on the brain. If there is a dietary deficiency of Omega-3 fatty acids, the brain’s natural cannabinoid system is not going to work with optimal efficiency, Dr. Laviolette explained.

“By contrast, if you can supplement with Omega-3 fatty acids you see certain improvements in the brain’s cannabinoid system, so that immediately got us interested in how synergies between Omega-3 fatty acids and cannabinoids that are derived from marijuana might serve as potential, novel pharmaceutical and nutraceutical products for treating certain specific mental health disorders.”

The brain’s natural cannabinoid system is involved in a lot of different processes that relate to mental health, including mood regulation, one’s ability to learn and remember, and certain cognitive tasks.

“We know in certain mental health disorders like depression, addiction and schizophrenia, there’s a lot of disturbance in this cannabinoid system,” Dr. Laviolette continued. “So oftentimes people will sort of self-medicate with marijuana and perhaps expose themselves to some of the more negative aspects of it. One compound, in particular, called THC (tetrahydrocannabinol), can have negative effects, especially in younger adults, especially adolescents.”

Dr. Laviolette and his team have been comparing and contrasting THC versus other cannabinoids found in marijuana and seek to answer the question of: “What are some of the molecular pathways that they activate and how can we modulate different phytocannabinoids in their formulations and combine them with Omega-3’s to make them less likely to produce some of the negative side effects possible with marijuana exposure?”

“We’re looking at both the positive and negative effects, with the goal of really reducing or eliminating the negative effects and really sort of amplifying the positive chemicals that are found in marijuana in terms of treating some of these illnesses,” Dr. Laviolette said.

One of the biggest concerns of the medical community, and one reason a lot of doctors are not very willing to prescribe their patients cannabinoids in terms of treating mental health symptoms like PTSD, depression or even schizophrenia, relates to the potential negative side effects, he added.

“What we’re really trying to do is tease apart the positive and negative aspects of marijuana. We’ve been able to show CBD can actually be a promising treatment for a variety of mental health disorders like PTSD and schizophrenia,” Dr. Laviolette said. “It’s quite amazing because, when you think about it, it’s the same plant but these two different, competing chemicals are producing different effects in terms of mental health.”

Another major issue associated with using cannabinoids as a medical treatment is that people “aren’t really too keen on the idea of just smoking cannabinoids,” he said. “So, one of the major research directions we’re taking with Algae Dynamics is coming up with more effective non-smoked formats of medical marijuana, which includes oil-based formulations.”

Algae Dynamics’s focus on supporting research directed at the medical benefits of cannabis and hemp oils is providing a critical lifeline to scientists like Dr. Laviolette.

“The other aspect is that it’s very difficult to do this research because of all the different government regulations that you need to go through to, first; get ahold of the actual compounds, and second; get the actual license to perform these sorts of studies,” he said.

Canada is heading toward legalization of cannabis throughout the country in 2018, which could bode well for the research community, investors and companies like Algae Dynamics.

“People are excited. I think there’s a general feeling that cannabinoids are absolutely going to be an emerging biotechnology in the coming decades,” said Dr. Laviolette. “Companies like Algae Dynamics are actually taking this research seriously and are getting in on the ground floor of the development of effective cannabinoid products.”

While solid, quality research takes time, Dr. Laviolette said his team is now moving toward the clinical realm with the goal of collaborating with clinicians sometime within the next few months. Discovering the ideal ratios of THC and CBD and then combining those with a nutritional supplement such as Omega-3 fatty acids is expected to lead to the best formulations for an early stage clinical trial.

“I think there’s tremendous potential for development of pharmaceuticals and nutraceuticals based on that,” Dr. Laviolette says. “I’ve been doing this research for well over two decades now and what you consistently realize is that the existing drugs available for treating some of these symptoms have some really bad side effects. So, it’s not only the limited effectiveness of a lot of these drugs used to treat depression and anxiety, but the serious side effects that make a lot of people stop taking them. It’s essentially a barrier of sorts to long term treatment.”

Dr. Laviolette’s research is providing early, promising evidence that there are very few side effects associated with cannabidiol, or CBD, which is a non-psychoactive compound in marijuana.

“I think there’s tremendous potential to develop pharmacological treatments that are derived from natural products that are relatively pure. I think they’ll be a much more promising alternative than the more traditional medications that are out there right now,” he added.

Cannabis is a complex plant with well over 100 different phytochemicals, a fact that Dr. Laviolette describes as exciting but also one that means researchers are just barely beginning to “scratch the surface.”

For more information about Dr. Laviolette and his research with Algae Dynamics, visit the company’s website at www.AlgaeDynamics.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php